Mereo BioPharma Group plc (MAH0) — Working Capital to Net Assets Ratio
Mereo BioPharma Group plc (MAH0) has a Working Capital to Net Assets ratio of 99.5% as of December 2025. Working capital of €40.72 Million (current assets of €45.02 Million minus current liabilities of €4.30 Million) is measured against net assets of €40.92 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See MAH0 net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Mereo BioPharma Group plc Working Capital to Net Assets (2016–2025)
This chart shows how Mereo BioPharma Group plc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of December 2025, the ratio stands at 99.5%, reflecting working capital of €40.72 Million against net assets of €40.92 Million EUR. Check Mereo BioPharma Group plc (MAH0) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Mereo BioPharma Group plc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Mereo BioPharma Group plc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see MAH0 company net worth.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 99.5% | €40.72 Million | €40.92 Million | €45.02 Million | €4.30 Million | ▼ -0.4 pp |
| 2024 | 99.9% | €60.91 Million | €60.97 Million | €74.76 Million | €13.85 Million | ▼ -7.5 pp |
| 2023 | 107.4% | €54.27 Million | €50.54 Million | €63.76 Million | €9.49 Million | ▲ +46.9 pp |
| 2022 | 60.5% | €37.45 Million | €61.87 Million | €62.13 Million | €24.68 Million | ▼ -38.1 pp |
| 2021 | 98.6% | €86.78 Million | €88.00 Million | €99.32 Million | €12.54 Million | ▲ +240.0 pp |
| 2020 | -141.3% | €21.16 Million | €-14.97 Million | €29.73 Million | €8.56 Million | ▼ -142.7 pp |
| 2019 | 1.4% | €557.00K | €40.26 Million | €30.43 Million | €29.88 Million | ▼ -54.5 pp |
| 2018 | 55.9% | €18.32 Million | €32.77 Million | €34.49 Million | €16.18 Million | ▼ -29.8 pp |
| 2017 | 85.7% | €53.56 Million | €62.48 Million | €63.18 Million | €9.62 Million | ▲ +13.1 pp |
| 2016 | 72.6% | €57.57 Million | €79.26 Million | €60.78 Million | €3.21 Million | — |